InvestorsHub Logo

PhenixBleu

03/14/18 9:23 AM

#36113 RE: Danorocket #36108

Nonsense? The product VitaStem is claimed to be based on the SSPT technology owned by competitor Kasten.

Line 52 from Kasten's recent Complaint (to be refiled) states:

ViaDerma, Neurogenx, and Biogenx also sell a product called TetraStem or VitaStem, which is based on OPD’s SSPT™.

Yes a little over 30-50 million shares since November 30 35 is not Massive at all. Massive is 500 million come on people Omg. Yes don't like to see it but we have a product that works and is in preliminary marketing and sales yes SALES with more products in the pipeline to follow. Just do the DD Crazy the nonsense that comes through this board. IMO VDRM